Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| INKINE PHARMACEUTICAL CO INC | 77,500 | reported | 26 Sept 2003 | tx 13+979,750−1,519,750 |
| BRADLEY PHARMACEUTICALS INC | 1,000 | reported | 30 Mar 2007 | tx 10+51,000 |
| ANTARES PHARMA INC | 0 | reported | 24 May 2022 | tx 89+2,814,078−2,764,720 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 138,901 | 5.60 USD | |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 31,674 | 5.60 USD | |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 153,097 | — | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 77,662 | — | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 60,407 | — | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 160,636 | — | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 300,000 | — | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 198,789 | — | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 123,860 | — | deriv |
| 24 May 2022 | OTHER | ANTARES PHARMA INC | 73,431 | — | deriv |
| 26 Oct 2021 | GIFT | ANTARES PHARMA INC | 125,000 | 0.00 USD | |
| 27 Aug 2021 | GRANT_AWARD | ANTARES PHARMA INC | 24,679 | 2.24 USD | |
| 27 Aug 2021 | TAX_WITHHOLDING | ANTARES PHARMA INC | 13,820 | 4.00 USD | |
| 27 Aug 2021 | EXERCISE | ANTARES PHARMA INC | 24,679 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | ANTARES PHARMA INC | 31,674 | 4.42 USD | |
| 10 Jun 2021 | GRANT_AWARD | ANTARES PHARMA INC | 60,407 | 0.00 USD | deriv |
| 18 Feb 2021 | SALE | ANTARES PHARMA INC | 15,321 | 5.05 USD | |
| 18 Feb 2021 | EXERCISE | ANTARES PHARMA INC | 15,321 | 2.24 USD | |
| 18 Feb 2021 | EXERCISE | ANTARES PHARMA INC | 15,321 | 0.00 USD | deriv |
| 11 Jun 2020 | GRANT_AWARD | ANTARES PHARMA INC | 40,293 | 2.73 USD | |
| 11 Jun 2020 | GRANT_AWARD | ANTARES PHARMA INC | 77,662 | 0.00 USD | deriv |
| 09 Dec 2019 | SALE | ANTARES PHARMA INC | 80,000 | 4.63 USD | |
| 09 Dec 2019 | EXERCISE | ANTARES PHARMA INC | 80,000 | 1.60 USD | |
| 09 Dec 2019 | SALE | ANTARES PHARMA INC | 80,000 | 4.62 USD | |
| 09 Dec 2019 | EXERCISE | ANTARES PHARMA INC | 80,000 | 1.66 USD |
3 purchases reported after at least 12 months of silence — most recent on 18 Mar 2016.